Age, y, mean ± SD (range) | 55.7 ± 19.8 (16–87) | 55.2 ± 20.1 (2–95) | 0.89 |
Sex, men, n (%) | 34 (69.4%) | 119 (62.0%) | 0.34 |
Comorbidity, n (%) | | | |
Malignancy | 10 (20.4%) | 32 (16.7%) | 0.54 |
Congestive heart failure | 2 (4.1%) | 16 (8.3%) | 0.31 |
Coronary artery disease | 8 (16.3%) | 23 (12.0%) | 0.42 |
Chronic obstructive pulmonary disease | 3 (6.12%) | 14 (7.29%) | 0.775 |
Hypertension | 22 (44.90%) | 91 (47.40%) | 0.756 |
Hyperlipidemia | 14 (28.57%) | 45 (23.44%) | 0.456 |
Diabetes mellitus | 14 (28.57%) | 35 (18.23%) | 0.108 |
Liver disease | 3 (6.12%) | 6 (3.13%) | 0.323 |
Chronic kidney disease | 6 (12.24%) | 15 (7.81%) | 0.326 |
Alcohol abuse, n (%) | 3 (6.12%) | 23 (11.98%) | 0.238 |
Drug abuse, n (%) | 2 (4.08%) | 18 (9.38%) | 0.231 |
Anticoagulant use, n (%) | 7 (14.29%) | 21 (10.94%) | 0.514 |
Antiplatelet use, n (%) | 12 (24.49%) | 21 (10.94%) | 0.014 |
Prior site surgery, n (%) | 11 (22.45%) | 48 (25.00%) | 0.711 |
Neurological deficit, n (%) | 24 (50.00%) | 84 (44.27%) | 0.476 |
American Spinal Injury Association impairment scale, n (%) | | | 0.083 |
A | 4 (8.51%) | 20 (11.05%) | |
B | 3 (6.12%) | 26 (14.36%) | |
C | 8 (17.02%) | 28 (15.47%) | |
D | 24 (51.06%) | 56 (30.94%) | |
E | 8 (17.02%) | 51 (28.18%) | |
American Society of Anesthesiologists class, n (%) | | | 0.062 |
1 or 2 | 10 (20.41%) | 43 (22.40%) | |
3 | 25 (51.02%) | 68 (33.42%) | |
4 or 5 | 14 (28.57%) | 81 (42.19%) | |